Public lists: Medical Devices (6123)

UIQI2 is designed to develop and utilize in-house processes and technical infrastructure for the conduct of imaging-based multi-center trials. The main objective is to develop infrastructure within the University of Iowa, which will support the pulmonary imaging portion of government and industry-based multi-center trials. The target audience is government and corporate sponsored multi-centered pre-clinical and clinical trials; specifically the Pharmaceutical and Device sectors of the medical in...Show all

UIQI2 is designed to develop and utilize in-house processes and technical infrastructure for the conduct of imaging-based multi-center trials. The main objective is to develop infrastructure within the University of Iowa, which will support the pulmo...Show all

Company (Alive / Active)

Phone:

Fax:

Suite 223 Technology Innovation Center
University of Iowa
Iowa City, 52242
Iowa, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
QI2 $0M Nov 30, 2018
See all 15 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related QI2 Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 1 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors

Aradigm Corporation

Hayward, California, United States
IPO / Went publicAradigm is an emerging specialty pharmaceutical company developing and commercializing a portfolio of drugs delivered by inhalation for the treatment of severe respiratory disease. Bolstered by its depth of expertise in pulmonary drug delivery and an extensive intellectual property portfolio, the Company is uniquely positioned to fulfill unmet needs in pulmonary medicine.Login to see details

Profound Medical

Toronto, Ontario, Canada
IPO / Went publicProfound Medical is a Canadian medical device company that has developed a unique and minimally invasive treatment to ablate the prostate gland. Profound's novel technology combines Magnetic Resonance Imaging (MRI) technology with ultrasound thermal energy that is delivered via a trans-urethral approach. This method of prostate cancer therapy provides highly accurate and precise treatment within the prostate in a short time span, allowing for fast patient recovery. The potential of this technolo...Show allLogin to see details
See all 15 competitors